Equasens SA
PAR:EQS

Watchlist Manager

Equasens SA

PAR:EQS

Watchlist

Dividends

Discount Rate

Price: 43.25 EUR 0.12% Market Closed

Market Cap: 650.1m EUR

Have any thoughts about
Equasens SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 43.25 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

EQS Alert

Equasens SA

43.25

+0.05 (+0.12%)

52 Week Range	40.15 66.9
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Equasens SA

What unique competitive advantages
does Equasens SA hold over its rivals?

What risks and challenges
does Equasens SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Equasens SA.

What unique competitive advantages
does Equasens SA hold over its rivals?

What risks and challenges
does Equasens SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Equasens SA.

Provide P/S
for Equasens SA.

Provide P/E
for Equasens SA.

Provide P/OCF
for Equasens SA.

Provide P/FCFE
for Equasens SA.

Provide P/B
for Equasens SA.

Provide EV/S
for Equasens SA.

Provide EV/GP
for Equasens SA.

Provide EV/EBITDA
for Equasens SA.

Provide EV/EBIT
for Equasens SA.

Provide EV/OCF
for Equasens SA.

Provide EV/FCFF
for Equasens SA.

Provide EV/IC
for Equasens SA.

Show me price targets
for Equasens SA made by professional analysts.

What are the Revenue projections
for Equasens SA?

How accurate were the past Revenue estimates
for Equasens SA?

What are the Net Income projections
for Equasens SA?

How accurate were the past Net Income estimates
for Equasens SA?

What are the EPS projections
for Equasens SA?

How accurate were the past EPS estimates
for Equasens SA?

What are the EBIT projections
for Equasens SA?

How accurate were the past EBIT estimates
for Equasens SA?

Compare the revenue forecasts
for Equasens SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Equasens SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Equasens SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Equasens SA compared to its peers.

Compare the P/E ratios
of Equasens SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Equasens SA with its peers.

Analyze the financial leverage
of Equasens SA compared to its main competitors.

Show all profitability ratios
for Equasens SA.

Provide ROE
for Equasens SA.

Provide ROA
for Equasens SA.

Provide ROIC
for Equasens SA.

Provide ROCE
for Equasens SA.

Provide Gross Margin
for Equasens SA.

Provide Operating Margin
for Equasens SA.

Provide Net Margin
for Equasens SA.

Provide FCF Margin
for Equasens SA.

Show all solvency ratios
for Equasens SA.

Provide D/E Ratio
for Equasens SA.

Provide D/A Ratio
for Equasens SA.

Provide Interest Coverage Ratio
for Equasens SA.

Provide Altman Z-Score Ratio
for Equasens SA.

Provide Quick Ratio
for Equasens SA.

Provide Current Ratio
for Equasens SA.

Provide Cash Ratio
for Equasens SA.

What is the historical Revenue growth
over the last 5 years for Equasens SA?

What is the historical Net Income growth
over the last 5 years for Equasens SA?

What is the current Free Cash Flow
of Equasens SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Equasens SA.

EV/FCFF
Enterprise Value to FCFF

16.3

Current

22.5

Median

Industry

Lower than median

Lower than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF

16.3

Enterprise Value

640.1m EUR

FCFF

39.3m EUR

All Countries

Forward Multiples

			Market Cap	EV/FCFF
FR		Equasens SA PAR:EQS	650.1m EUR	16.3
US		Veeva Systems Inc NYSE:VEEV	36.3B USD	29.7
US	C	Cerner Corp LSE:0R00	31.3B USD	28.3
AU		Pro Medicus Ltd ASX:PME	26.6B AUD	351.5
US		Doximity Inc NYSE:DOCS	10.8B USD	46
US	W	Waystar Holding Corp NASDAQ:WAY	6.3B USD	83
JP		M3 Inc TSE:2413	927.2B JPY	15.7
US		Inspire Medical Systems Inc NYSE:INSP	5.6B USD	136.5
SE		Sectra AB STO:SECT B	52.8B SEK	461.7
US	V	Vocera Communications Inc F:V00	2.4B EUR	59.3
CN		Winning Health Technology Group Co Ltd SZSE:300253	16.7B CNY	443.9


FR		Equasens SA PAR:EQS	Average EV/FCFF: 152 16.3
US		Veeva Systems Inc NYSE:VEEV	29.7
US	C	Cerner Corp LSE:0R00	28.3
AU		Pro Medicus Ltd ASX:PME	351.5
US		Doximity Inc NYSE:DOCS	46
US	W	Waystar Holding Corp NASDAQ:WAY	83
JP		M3 Inc TSE:2413	15.7
US		Inspire Medical Systems Inc NYSE:INSP	136.5
SE		Sectra AB STO:SECT B	461.7
US	V	Vocera Communications Inc F:V00	59.3
CN		Winning Health Technology Group Co Ltd SZSE:300253	443.9

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/FCFF

N/A

2-Years Forward

EV/FCFF

N/A

3-Years Forward

EV/FCFF

N/A

	Franklin Covey Co NYSE:FC	36.41 USD -1.03%
	Mohawk Industries Inc NYSE:MHK	119.16 USD 2%
	Ardmore Shipping Corp NYSE:ASC	11.31 USD 0.18%
	ASGN Inc NYSE:ASGN	83.87 USD -0.97%
	Skyworks Solutions Inc NASDAQ:SWKS	88.75 USD 0.56%
	Weatherford International PLC NASDAQ:WFRD	67.1 USD -2.13%

	Johnson & Johnson NYSE:JNJ	144.47 USD 0.62%
	Bank of America Corp NYSE:BAC	44.17 USD 1.82%
	Mastercard Inc NYSE:MA	528.03 USD 0.91%
	Salesforce Inc NYSE:CRM	343.65 USD 2.21%
	Abbvie Inc NYSE:ABBV	175.58 USD 2.37%
	Home Depot Inc NYSE:HD	392.6 USD 1.97%

	Arista Networks Inc NYSE:ANET	112.81 USD 3.43%
	Visa Inc NYSE:V	317.71 USD 0.9%
	Texas Pacific Land Corp NYSE:TPL	1 133.12 USD 3.36%
	KLA Corp NASDAQ:KLAC	629.37 USD 1.16%
	Manhattan Associates Inc NASDAQ:MANH	280.26 USD -0.81%
	Pinduoduo Inc NASDAQ:PDD	99.51 USD -1.48%

	Salesforce Inc NYSE:CRM	343.65 USD 2.21%
	Accenture PLC NYSE:ACN	366.37 USD -1.56%
	ServiceNow Inc NYSE:NOW	1 091.25 USD 1.52%
	EOG Resources Inc NYSE:EOG	119.04 USD 0.69%
	Copart Inc NASDAQ:CPRT	58.22 USD -0.39%
	Applied Materials Inc NASDAQ:AMAT	163.59 USD 1.33%

Equasens SA
PAR:EQS

EV/FCFF
Enterprise Value to FCFF

EV/FCFF Forward Multiples

See Also

Company

Help

Tools

Stocks

Equasens SA PAR:EQS

EV/FCFF Enterprise Value to FCFF

EV/FCFF Forward Multiples

See Also

Company

Help

Tools

Stocks

Equasens SA
PAR:EQS

EV/FCFF
Enterprise Value to FCFF